Menu
Login
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
4.21.23 Understanding and Treating Anxiety Disorders & OCD in Children and Adolescents
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
10 Columbus Blvd.
Hartford, CT 06105
General Information
Active Dates
Friday, April 21, 2023 - Tuesday, April 21, 2026
Estimated Completion Time
60 minutes
Conference Host
Connecticut Children's
Conference Location
Virtual Conference Room
Conference Name
(On-Demand) Ask The Experts 22-23
Provider
Connecticut Children's
Watch this Lecture Remotely
Objectives
Series Objectives
Summarize current, real time events happening around the world to our in-house faculty and community pediatricians
Review questions provided during the extended Q&A
Integrate current events and advances into daily practices.
Event Objectives
Understand the factors that maintain anxiety disorders and OCD.
Identify cognitive behavioral interventions in the treatment of anxiety disorders and OCD.
Understand the impact of family accommodation on anxiety and OCD.
Presentations and Speakers
4.21.23 Understanding and Treating Anxiety Disorders & OCD in Children and Adolescents
Scott Hannan, PhD
Available Credits/Points
Credit Designation
Connecticut Children's Office of Continuing Medical Education designates this enduring material for a maximum of 1
AMA PRA Category 1 Credit
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Connecticut Children's designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Classifications
STATE MANDATED TOPIC
Disclosure Statements
Event Disclosures
Speakers:
Scott Hannan, PhD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
Pfizer - own stock - Relationship Has Not Ended
Viatris - own stock - Relationship Has Not Ended
Any financial relationship that was found to be relevant has been mitigated.
ACCREDITATION: Connecticut Children’s is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Connecticut Children's designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only credits commensurate with the extent of their participation in the various activities. Conflict of Interest Policy: All faculty participating in Continuing Medical Education activities sponsored by Connecticut Children’s are required to disclose to the program audience any actual or perceived conflict of interest related to the content of their presentation. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content. Dr. Scott Hannan owns stock in Pfizer and Viatris. All relevant financial relationships have been mitigated according to ACCME guidelines. The additional planners and activity director does not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. The speaker(s) will not be discussing the use of any off-label product.
Commercial Support
This activity is not commercially supported.
Accreditation Statement
Connecticut Children's is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Connecticut Children's takes responsibility for the content, quality, and scientific integrity of this CME activity.
Test Information
Percentage of Correct Responses Required to Pass
100 %
Percentage of Responses Required to Submit
100 %
Last Review Date
3/22/2023
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement